Let me congratulate Tekedia Capital portfolio company, Revna Biosciences, for a strategic partnership with Georgetown University’s McDonough School of Business, USA. Through this partnership, students from the American university will support Revna Biosciences’ strategic expansion into the West African and broader African markets, as it continues to advance molecular diagnostics and clinical research.
Ultimately, this will expose the students to real-world scenarios, thereby gaining invaluable practical experience, even as they work to accelerate Revnabio’s mission to improve patient outcomes across Africa.
RevnaBio is fully licensed as a tertiary laboratory by the Health Facilities Regulatory Agency (HeFRA) and maintains compliance with the Data Protection Act (DPA). The diagnostic tests bear the CE-IVD mark or are equivalent to US-FDA standards. Upholding the highest quality standards, Revna Biosciences is an active member of the American Association for Laboratory Accreditation (A2LA) and has a medical lab campus in Accra.
Register for Tekedia Mini-MBA edition 19 (Feb 9 – May 2, 2026): big discounts for early bird.
Tekedia AI in Business Masterclass opens registrations.
Join Tekedia Capital Syndicate and co-invest in great global startups.
Register for Tekedia AI Lab: From Technical Design to Deployment (next edition begins Jan 24 2026).
I am also using the opportunity to note that Revanibio will be looking for strategic partners in Nigeria and other African countries as it begins a massive scaling phase. When you think of Quest or LabCorp in the United States, I want you to think of Revnabio of Africa.
As a Board Member of Revnabio, I’m thrilled on the promises this company has for Africa. It began in Ghana; it will scale across Africa. Contact Derrick Edem Akpalu, PhD, MSCR, CEO of Revnabio, or myself if you’re interested to partner.
About Revna Biosciences: Revna Biosciences is a premier precision medicine research company based in Ghana, known for its advanced molecular diagnostic services and clinical research. The company stands as a beacon of precision medicine innovation in Ghana, offering state-of-the-art molecular diagnostics and driving a significant paradigm shift in advanced molecular diagnostics across the African continent. For more, visit t www.revnabio.com.
For the LinkedIn contacts, click here.
---
Connect via my
LinkedIn |
Facebook |
X |
TikTok |
Instagram |
YouTube